Thuja Capital
Investor profile
Thuja Capital has backed 11 European tech companies across 13 funding rounds between 2014 and 2026, joining rounds totalling €163M. Most active in Healthtech and Hardware. Data as of Nov 2026.
Deals
13
distinct rounds
Companies
11
backed
Active span
2014–2026
13 yrs
Total round €
€163M
sum of rounds joined
Deals by year
distinct rounds / yearThuja Capital — deals by year — interactive chart.
Data table
| Thuja Capital — deals by year | |
|---|---|
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Top sectors
by dealsThuja Capital — top sectors — interactive chart.
Data table
| Thuja Capital — top sectors | |
|---|---|
| Healthtech | 13 |
| Hardware | 1 |
Stages
by dealsThuja Capital — stages — interactive chart.
Data table
| Thuja Capital — stages | |
|---|---|
| Series A | 6 |
| Seed | 3 |
| Series B | 2 |
| Early VC | 1 |
| Other | 1 |
Countries
by dealsThuja Capital — countries — interactive chart.
Data table
| Thuja Capital — countries | |
|---|---|
| Netherlands | 9 |
| Germany | 2 |
| Belgium | 1 |
| France | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- BioGeneration Ventures2
- Flerie Invest2
- High-Tech Gründerfonds (HTGF)2
- INKEF Capital2
- 819 Capital1
- Ackermans & van Haaren1
- Asabys Partners1
- BNP Paribas Fortis Private Equity1
- Boehringer Ingelheim Venture Fund (BIVF)1
- Bolwork International Investment1
- Brabant Development Agency1
- Brabant Development Agency (BOM)1
- Casdin Capital1
- Chemelot Ventures1
- Creathor Venture1
- Dolby Family Ventures1
- dsm-firmenich Ventures1
- EIC Fund1
- Eurazeo1
- Flanders Future Techfund (FFTF)1
- FundPlus1
- Gilde Healthcare1
- Health Innovations1
- Index Ventures1
- Innovation Industries1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Salvia BioElectronics | Netherlands | 1 | €53M |
| AstriVax | Belgium | 1 | €30M |
| Gradient Denervation Technologies | France | 1 | €14M |
| NightBalance | Netherlands | 1 | €13M |
| Synerkine Pharma | Netherlands | 3 | €12M |
| tacalyx | Germany | 1 | €11M |
| FundaMental Pharma | Germany | 1 | €10M |
| InnoSIGN | Netherlands | 1 | €7.3M |
| Cristal Therapeutics | Netherlands | 1 | €6.0M |
| EnCare Biotech | Netherlands | 1 | €4.4M |
| ATRO Medical | Netherlands | 1 | €3.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Salvia BioElectronics | Series B | €53M | 2025-05 |
| AstriVax | Seed | €30M | 2022-08 |
| Gradient Denervation Technologies | Series A | €14M | 2023-09 |
| NightBalance | Series B | €13M | 2016-07 |
| tacalyx | Seed | €11M | 2026-04 |
| FundaMental Pharma | Seed | €10M | 2022-11 |
| InnoSIGN | Series A | €7.3M | 2022-04 |
| Cristal Therapeutics | Early VC | €6.0M | 2014-12 |
| Synerkine Pharma | Series A | €5.3M | 2023-10 |
| EnCare Biotech | Series A | €4.4M | 2014-11 |